Dolby Laboratories, Inc.

NYSE:DLB

72.61 (USD) • At close September 19, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

20232022202120202019201820172016201520142013201220112010200920082007200620052004200320022001
Revenue 1,009.1821,253.7931,281.2561,161.7921,241.621,171.9241,081.4541,025.738967.41960.176909.674926.264955.505922.713719.503640.231482.028391.542327.967289.041217.472161.868124.653
Cost of Revenue 117.014141.36130.025146.498160.854128.26118.307108.98294.79670.17696.71992.027111.171131.81564.76867.77774.26576.04280.21891.50573.64357.71750.442
Gross Profit 892.1681,112.4331,151.2311,015.2941,080.7661,043.664963.147916.756872.614890812.955834.237844.334790.898654.735572.454407.763315.5247.749197.536143.829104.15174.211
Gross Profit Ratio 0.8840.8870.8990.8740.870.8910.8910.8940.9020.9270.8940.9010.8840.8570.910.8940.8460.8060.7550.6830.6610.6430.595
Reseach & Development Expenses 201.097261.174253.64239.045237.871236.794233.312219.607200.892183.128168.746140.143123.92104.97866.7162.0844.10935.37730.53223.47918.26215.12816.106
General & Administrative Expenses 191.865275.315224.161219.753205.425197.516171.686168.854181.981178.104161.97149.175137.633119.353000000000
Selling & Marketing Expenses 263.494358.716332.671335.933343.835309.802296.661295.267278.92252.647231.103181.736149.642130.16000000000
SG&A 455.359634.031556.832555.686549.26507.318468.347464.121460.901430.751393.073330.911287.275249.513225.489224.09178.802154.165135.155106.45676.59048.244
Other Expenses 02.57.1088.4340.481-5.903-1.438-1.4528.193-1.1462.1116.999160.01111.84-5.977-0.499-2.1-3.625-2-2000
Operating Expenses 656.456895.205810.472794.731787.131744.112701.659683.728661.793613.879561.819471.054411.195354.491286.222285.671220.811185.917163.687127.93594.85215.12864.35
Operating Income 219.247206.605344.39218.742257.077299.998248.632231.795210.901273.718245.262361.992429.733429.381363.666286.783186.952129.58384.06267.86347.6670.5499.861
Operating Income Ratio 0.2170.1650.2690.1880.2070.2560.230.2260.2180.2850.270.3910.450.4650.5050.4480.3880.3310.2560.2350.2190.0030.079
Total Other Income Expenses Net 21.7738.67410.12220.97325.23-5.457-14.294-2.68328.273-3.549-3.7635.8087.5040.6052.906-0.2451.5193.724.0471.403-0.219-0.747-3.369
Income Before Tax 241.02215.279354.512239.715282.307312.867256.644235.904243.455276.099250.646368.991440.643437.012371.419301.802209.416146.63791.21868.09247.61-0.1986.492
Income Before Tax Ratio 0.2390.1720.2770.2060.2270.2670.2370.230.2520.2880.2760.3980.4610.4740.5160.4710.4340.3750.2780.2360.219-0.0010.052
Income Tax Expense -49.28431.38136.6898.09626.802190.06254.21749.50262.25767.37960.344103.857130.061154.185127.073100.7765.13155.83337.3327.32116.0790.0114.21
Net Income 191.47184.087310.227231.363255.151122.246201.802185.86179.335206.103189.271264.302309.267283.447242.991199.458142.83189.54952.29339.84230.969-0.1055.651
Net Income Ratio 0.190.1470.2420.1990.2050.1040.1870.1810.1850.2150.2080.2850.3240.3070.3380.3120.2960.2290.1590.1380.142-0.0010.045
EPS 21.843.072.32.511.181.981.851.752.021.862.472.782.52.151.791.310.850.540.470.36-0.0010.07
EPS Diluted 1.961.812.972.252.441.141.951.811.731.991.842.462.752.462.111.741.260.80.50.430.36-0.0010.07
EBITDA 219.247329.905464.117332.6404.158393.902353.935322.414312.691331.802310.34408.25469.629470.739394.339311.842200.238138.72591.36376.71556.69489.0239.861
EBITDA Ratio 0.2170.2630.3620.2860.3260.3360.3270.3140.3230.3460.3410.4410.4910.510.5480.4870.4150.3540.2790.2650.2610.550.079